Alan J Lenox-Smith

Summary

Affiliation: Wyeth Research
Country: USA

Publications

  1. ncbi A double-blind, randomised, placebo controlled study of venlafaxine XL in patients with generalised anxiety disorder in primary care
    Alan J Lenox-Smith
    Medical Department, Wyeth Pharmaceuticals, Huntercombe Lane South, Taplow, SL6 0PH
    Br J Gen Pract 53:772-7. 2003
  2. ncbi Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor
    Alan J Lenox-Smith
    Wyeth UK, Huntercombe Lane South, Slough, UK
    Int Clin Psychopharmacol 23:113-9. 2008

Detail Information

Publications2

  1. ncbi A double-blind, randomised, placebo controlled study of venlafaxine XL in patients with generalised anxiety disorder in primary care
    Alan J Lenox-Smith
    Medical Department, Wyeth Pharmaceuticals, Huntercombe Lane South, Taplow, SL6 0PH
    Br J Gen Pract 53:772-7. 2003
    ..This study was set up to investigate venlafaxine XL in a more naturalistic population of patients with GAD...
  2. ncbi Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor
    Alan J Lenox-Smith
    Wyeth UK, Huntercombe Lane South, Slough, UK
    Int Clin Psychopharmacol 23:113-9. 2008
    ..Patients who remain severely depressed following treatment with an SSRI may gain more benefit from the dual-action drug venlafaxine, rather than switching to another SSRI...